Epivir 150 mg Tablets

Epivir 150 mg tablets and the available choice

Epivir is the brand name for lamivudine, a nucleoside reverse transcriptase inhibitor (NRTI). The product covered here consists of 150 mg tablets taken by mouth. We offer this single strength in six quantities, ranging from 30 to 240 tablets. The strength, active ingredient, dosage form and route remain the same whichever quantity you choose.

The practical decision is therefore not whether lamivudine belongs in your treatment. That is a clinical decision made with a prescriber as part of an HIV treatment plan. The choice here is which available quantity matches the amount prescribed, the timing of your next review, your preferred ordering frequency and the amount you are prepared to spend at one time.

HIV treatment is commonly long term, but a larger quantity is not automatically more suitable. A treatment review, a planned change to the wider regimen or uncertainty about how long the same dose will continue may make a smaller supply more appropriate. Conversely, someone with an established prescription and adequate storage space may prefer to order less frequently. These practical differences matter even though every option contains the same Epivir 150 mg tablets.

Package options and unit value

The comparison below presents our current available quantities, exact prices, unit values and relative savings. It allows you to compare the financial effect of the options without relying on estimated market prices or unrelated pharmacy offers.

Unit value is useful, but it should be considered only after confirming that the quantity is medically appropriate. A lower price per tablet does not make excess medicine good value if your prescription, dose or wider antiretroviral regimen is likely to change before the tablets are used. The most relevant comparison is between quantities that could realistically fit your current treatment plan.

Upfront cost also matters. A smaller quantity may have a higher unit value but require less spending at one time, while a larger quantity may reduce how often you reorder. Neither outcome is universally preferable. Check the total price as well as the price per tablet, then consider prescribed duration, review dates, storage and likely use before deciding.

Which quantity fits your treatment plan?

A package comparison becomes more useful when it is considered alongside the practical details of treatment. The following points can help narrow the choice without turning a price comparison into an individual dosing recommendation:

• Prescribed quantity and duration: choose only an amount consistent with the instructions and supply period set by your prescriber.
• Upcoming reviews: if your HIV regimen is due to be reviewed, avoid assuming that the same medicine, strength or dose will continue unchanged.
• Ordering frequency: a smaller quantity means more frequent reordering, while a larger quantity may reduce the number of orders required.
• Upfront cost: compare the total amount payable, not just the unit value, and select an option that is manageable without buying unnecessary stock.
• Storage and expiry: make sure the tablets can be stored correctly and are expected to be used before their stated expiry date.

Do not calculate treatment duration from the tablet count alone. Lamivudine dosing depends on the prescribed regimen and individual clinical factors, and a particular quantity may cover different periods for different people. The dispensing label and the instructions from the prescribing team take priority over any general package comparison.

It is also sensible to check how many tablets you already have before ordering. This reduces the risk of an avoidable gap while also helping prevent an unnecessary overlap of supplies. If the prescription and the selected quantity do not appear to match, confirm the intended amount with the prescriber or pharmacist rather than adjusting the dose or schedule yourself.

Brand identity and related antiretroviral medicines

Epivir is a brand of lamivudine. The brand name and active-ingredient name describe different aspects of the same product identity: Epivir identifies the branded medicine, while lamivudine identifies the active ingredient. This guide does not imply that a separate generic product is included in our current Epivir options.

For HIV, lamivudine is used as one component of combination antiretroviral therapy rather than as treatment on its own. The other components depend on the selected regimen. Some current regimens combine it with one additional active medicine, while others contain more components, so it would be inaccurate to assume that every patient must take the same number or type of accompanying medicines.

Medicines that may be discussed in the wider treatment context include:

• Abacavir: another NRTI that is used with lamivudine in some regimens, subject to clinical suitability and the required screening.
• Tenofovir-containing medicines: these can form part of alternative antiretroviral backbones, but they are not direct pack-for-pack substitutes for prescribed Epivir.
• Emtricitabine-containing medicines: emtricitabine is closely related to lamivudine and is generally not used concurrently with it.
• Entecavir: this medicine is primarily used for hepatitis B and should not be treated as an alternative HIV medicine simply because it is also a nucleoside analogue.

These medicines have distinct indications, combinations, precautions and prescribing requirements. A package-price decision for Epivir should not be used to change one antiretroviral medicine for another. Readers comparing the broader treatment area can also view our HIV range or the wider Anti Viral & Immunity category.

Established role in HIV treatment

Lamivudine has a long-established role in combination treatment for HIV infection. It helps reduce viral replication and supports viral suppression when used with the other medicines in an effective regimen. Successful treatment depends on the complete regimen, not on lamivudine alone, and continuing every component as directed helps reduce the risk of treatment failure and drug resistance.

The 150 mg tablet is an established adult presentation, but the presence of this strength does not determine the dose by itself. Kidney function and the design of the complete regimen can affect prescribing. People who need dose adjustment may require a different way of receiving lamivudine rather than simply changing the number of 150 mg tablets without clinical direction.

Lamivudine also has established paediatric uses from three months of age, but doses for children are based on age, body weight and clinical circumstances. A 150 mg tablet is not suitable for every child, even when the medicine itself is appropriate. Paediatric use and the choice of presentation must therefore be directed by the prescribing specialist rather than by package availability or unit price.

How does lamivudine work and how are the tablets used?

HIV uses an enzyme called reverse transcriptase to make genetic material needed for replication. Inside the body, lamivudine is converted to an active form that competes with the natural building blocks used during this process. Its incorporation interrupts the developing viral DNA chain, helping to limit further viral replication.

This action does not remove HIV from the body, and Epivir must not be used alone to treat HIV. It works as part of a combination regimen in which the medicines act together to maintain control of the virus. The tablets should be taken by mouth exactly as prescribed. They may be taken with or without food, but the dose and schedule on the dispensing label should always be followed.

Regular dosing is important because missed doses can reduce the effectiveness of the complete regimen. If a dose is forgotten, follow the instructions in the patient information leaflet or obtain advice from the prescribing team or a pharmacist. Do not take a double dose to compensate unless a healthcare professional has specifically instructed you to do so. Do not stop Epivir or alter the wider regimen independently, even if you feel well.

Store the tablets at 25°C; excursions from 15°C to 30°C are permitted. Keep medicines securely out of the sight and reach of children, and check the packaging and expiry date before use. If tablets have been exposed to conditions outside the stated range, ask a pharmacist for advice rather than assuming that they remain suitable.

Safety considerations and relevant interactions

Suitability depends on the person taking the medicine, the other components of the regimen and any additional health conditions. Important points to discuss with the prescribing team include:

• Allergy: Epivir must not be taken by anyone with known hypersensitivity to lamivudine or an excipient in the specific tablet.
• Kidney function: lamivudine is cleared mainly through the kidneys. Reduced kidney function may require dose adjustment, and the 150 mg tablet presentation may not allow every required adjustment.
• Pregnancy: lamivudine can be used during pregnancy when clinically needed, but treatment should be selected through an individual assessment of maternal benefit and fetal risk.
• Breastfeeding: UK guidance recommends that women living with HIV avoid breastfeeding to prevent postnatal transmission of HIV to the infant.
• Diabetes: antiretroviral treatment can be associated with metabolic changes, including increased blood glucose, so additional monitoring may be appropriate.
• Driving and machinery: malaise and fatigue have been reported. Consider how the illness and any adverse effects affect alertness before driving or operating machinery.
• Hepatitis B: lamivudine is also active against hepatitis B virus. In a person who has HIV and hepatitis B, stopping it can lead to worsening hepatitis, so treatment changes require clinical monitoring.

Tell the prescriber and pharmacist about prescription medicines, non-prescription products and supplements. In particular, avoid taking another product containing lamivudine at the same time unless it forms part of a specifically prescribed plan. Lamivudine and emtricitabine are closely related and are not normally combined.

Trimethoprim, which is present in co-trimoxazole, can increase exposure to lamivudine. This does not mean that the medicines can never be used together, but it makes it important for the clinical team to know about both. Interactions involving the other medicines in an HIV regimen may also affect the final treatment choice even when they do not directly alter lamivudine.

Seek urgent medical advice for signs of a serious allergic reaction or severe, unexplained symptoms. The information here supports an informed package comparison but does not replace the patient information leaflet, monitoring plan or advice from the HIV care team.

UK prescription status and our ordering policy

Epivir 150 mg film-coated tablets are authorised in the United Kingdom, and lamivudine tablets are classified as prescription-only medicines. Their clinical use should therefore be based on assessment and prescribing by an appropriate healthcare professional.

That regulatory classification is separate from our ordering process. Under our current ordering policy, we do not require customers to submit a prescription to us when placing an order. This does not change the medicine's UK classification, replace medical supervision or make self-directed changes to HIV treatment appropriate. Order only the medicine and quantity that form part of your established treatment plan, and consult the prescribing team if the regimen or intended supply is uncertain.

How do ordering, support and dispatch work with us?

Once you have confirmed the required quantity, select the corresponding Epivir 150 mg option. Our support team is available 24/7 by email, online chat and phone for questions about our options or the ordering process. We also have pharmacist support available for medicine-related questions.

1. Check that Epivir 150 mg tablets match the medicine and strength in your treatment plan.
2. Compare the available quantities, total prices and unit values shown above.
3. Select a quantity that is consistent with the intended supply rather than choosing solely on the lowest unit price.
4. Contact our support team for help with the order or ask for pharmacist support if your question concerns the medicine.
5. Complete the order details carefully, including the delivery address and postcode, so we can pack and dispatch the order.

General support staff can explain our listed options and ordering process, but questions about dosing, treatment duration, interactions or whether a particular quantity is clinically suitable should be directed to a pharmacist or the prescribing team. If a later review changes your treatment, reassess the quantity before the next order instead of automatically repeating a previous package size.

A balanced value decision

The best practical value is not automatically the largest package or the lowest price per tablet. It is the quantity that fits the prescribed supply, is likely to be used before expiry, can be stored correctly and has an acceptable upfront cost. The price comparison image makes the differences transparent, but it should support rather than override those considerations.

Before ordering, confirm the product name, 150 mg strength, tablet form and required quantity. Then compare total cost, unit value and expected ordering frequency among the medically appropriate options. This approach allows price to inform the decision without encouraging excess supply or an unplanned change to treatment.

If you need help understanding our package options or order process, our support team is available around the clock. For questions about Epivir itself, including dosing, missed doses, interactions or treatment changes, use our pharmacist support or contact the healthcare professional managing your HIV treatment.